- Corporate Officers - G
- Goldfischer Carl
Insider Trading History of Goldfischer Carl
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Goldfischer Carl since 2006.
The trader's CIK number is 1110780.
At the time of the last reporting, Goldfischer Carl was the Director of Epizyme, Inc.. (stock ticker symbol EPZM).
Also see all insider trading activities at Epizyme, Inc..
Note that in the past
GOLDFISCHER CARL also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Cymabay Therapeutics, Inc. (CBAY) by Goldfischer Carl
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | CBAY | 0 | $0 | 11,675 | $105,331 | 11,675 | $61,293 |
| 2018 | CBAY | 0 | $0 | 15,000 | $195,375 | 15,000 | $78,750 |
| 2017 | CBAY | 0 | $0 | 18,000 | $155,880 | 18,000 | $42,210 |
| 2015 | CBAY | 0 | $0 | 46,729 | $128,193 | 0 | $0 |
Yearly summary of insider trading at Reshape Lifesciences Inc. (ETRM) by Goldfischer Carl
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | ETRM | 0 | $0 | 4,668 | $22,639 | 0 | $0 |
| 2011 | ETRM | 840,000 | $1,386,000 | 0 | $0 | 0 | $0 |
| 2010 | ETRM | 1,700,000 | $2,958,000 | 0 | $0 | 0 | $0 |
| 2009 | ETRM | 1,649,485 | $1,896,907 | 0 | $0 | 0 | $0 |
| 2008 | ETRM | 145,590 | $573,833 | 0 | $0 | 0 | $0 |
| 2007 | ETRM | 375,000 | $3,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Epizyme, Inc. (EPZM) by Goldfischer Carl
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | EPZM | 5,000 | $60,350 | 0 | $0 | 0 | $0 |
| 2016 | EPZM | 555,555 | $4,999,995 | 0 | $0 | 0 | $0 |
| 2014 | EPZM | 0 | $0 | 1,037,333 | $33,404,052 | 0 | $0 |
| 2013 | EPZM | 166,666 | $2,499,990 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Neorx Corp (PARD) by Goldfischer Carl
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | PARD | 0 | $0 | 0 | $0 | 36,145 | $0 |
| 2007 | PARD | 60,114 | $377,617 | 0 | $0 | 0 | $0 |
| 2006 | PARD | 1,244,935 | $871,454 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Map Pharmaceuticals, Inc. (MAPP) by Goldfischer Carl
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | MAPP | 0 | $0 | 602,700 | $9,629,813 | 0 | $0 |
Insider trading activities at 5 companies by Goldfischer Carl:
1. Cymabay Therapeutics, Inc. (CBAY)
2. Reshape Lifesciences Inc. (ETRM)
3. Epizyme, Inc. (EPZM)
4. Neorx Corp (PARD)
5. Map Pharmaceuticals, Inc. (MAPP)
Table 1. Insider trading of Cymabay Therapeutics, Inc. (CBAY) by Goldfischer Carl
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-02-07 | CBAY | Option Ex | 11,675 | 5.25 | 61,293 |
| 2019-02-07 | CBAY | Sale | 11,675 | 9.02 | 105,331 |
| 2018-03-22 | CBAY | Sale | 15,000 | 13.03 | 195,375 |
| 2018-03-22 | CBAY | Option Ex | 15,000 | 5.25 | 78,750 |
| 2017-11-02 | CBAY | Sale | 18,000 | 8.66 | 155,880 |
| 2017-11-02 | CBAY | Option Ex | 18,000 | 2.35 | 42,210 |
| 2015-09-11 | CBAY | Sale | 15,467 | 2.76 | 42,735 |
| 2015-09-10 | CBAY | Sale | 16,500 | 2.71 | 44,715 |
| 2015-09-09 | CBAY | Sale | 14,762 | 2.76 | 40,743 |
Table 2. Insider trading of Reshape Lifesciences Inc. (ETRM) by Goldfischer Carl
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-05-25 | ETRM | Sale | 4,668 | 4.85 | 22,639 |
| 2011-09-23 | ETRM | Buy | 840,000 | 1.65 | 1,386,000 |
| 2010-12-14 | ETRM | Buy | 1,700,000 | 1.74 | 2,958,000 |
| 2009-02-19 | ETRM | Buy | 1,649,485 | 1.15 | 1,896,907 |
| 2008-10-24 | ETRM | Buy | 49,600 | 1.10 | 54,560 |
| 2008-04-29 | ETRM | Buy | 25,000 | 4.50 | 112,500 |
| 2008-04-24 | ETRM | Buy | 50,000 | 4.50 | 225,000 |
| 2008-02-29 | ETRM | Buy | 20,990 | 8.66 | 181,773 |
| 2007-11-15 | ETRM | Buy | 375,000 | 8.00 | 3,000,000 |
Table 3. Insider trading of Epizyme, Inc. (EPZM) by Goldfischer Carl
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-11-11 | EPZM | Buy | 5,000 | 12.07 | 60,350 |
| 2016-01-12 | EPZM | Buy | 555,555 | 9.00 | 4,999,995 |
| 2014-09-04 | EPZM | Sale | 4,000 | 35.14 | 140,560 |
| 2014-08-26 | EPZM | Sale | 200,000 | 35.14 | 7,027,800 |
| 2014-08-21 | EPZM | Sale | 38,666 | 33.03 | 1,277,331 |
| 2014-08-22 | EPZM | Sale | 128,000 | 32.46 | 4,154,752 |
| 2014-08-25 | EPZM | Sale | 200,000 | 35.77 | 7,153,600 |
| 2014-02-10 | EPZM | Sale | 466,667 | 29.25 | 13,650,009 |
| 2013-06-05 | EPZM | Buy | 166,666 | 15.00 | 2,499,990 |
Table 4. Insider trading of Neorx Corp (PARD) by Goldfischer Carl
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-06-09 | PARD | Option Ex | 36,145 | .00 | 0 |
| 2007-08-30 | PARD | Buy | 3,712 | 5.80 | 21,514 |
| 2007-08-29 | PARD | Buy | 244 | 5.75 | 1,402 |
| 2007-08-14 | PARD | Buy | 29 | 5.50 | 159 |
| 2007-08-16 | PARD | Buy | 227 | 5.48 | 1,244 |
| 2007-08-10 | PARD | Buy | 675 | 5.50 | 3,712 |
| 2007-04-30 | PARD | Buy | 55,227 | 6.33 | 349,586 |
| 2006-04-26 | NERX | Buy | 1,244,935 | .70 | 871,454 |
Table 5. Insider trading of Map Pharmaceuticals, Inc. (MAPP) by Goldfischer Carl
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-03-12 | MAPP | Sale | 105,000 | 16.30 | 1,711,500 |
| 2010-03-15 | MAPP | Sale | 42,176 | 16.01 | 675,237 |
| 2010-03-16 | MAPP | Sale | 115,610 | 16.20 | 1,872,882 |
| 2010-03-11 | MAPP | Sale | 54,300 | 16.06 | 872,057 |
| 2010-03-10 | MAPP | Sale | 134,190 | 16.03 | 2,151,065 |
| 2010-03-09 | MAPP | Sale | 151,424 | 15.50 | 2,347,072 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Goldfischer Carl
(Director of Epizyme, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.